Last reviewed: June 23, 2026
Last updated: June 23, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Ozempic, produces meaningful weight loss results—but side effects are common in the first 4–12 weeks of treatment. Studies indicate that roughly 70–80% of users report nausea, vomiting, constipation, or other gastrointestinal symptoms at some point. The good news: most side effects are temporary, dose-dependent, and manageable with proper medical guidance.
How Many People Experience Semaglutide Side Effects
Large-scale clinical trials tracked thousands of people taking semaglutide for weight loss and type 2 diabetes. Across these studies, approximately 25–40% of participants reported nausea as their primary side effect, making it the most common complaint. Vomiting occurred in about 10–15% of users, while constipation affected 15–20%. When researchers combined all gastrointestinal side effects together, the total percentage of people experiencing at least one symptom ranged from 70–80%, depending on the dose and individual factors.
Side effect severity follows a predictable pattern: most users tolerate low starting doses very well, but symptoms intensify as doses increase over weeks or months. The timing matters too—side effects typically peak during the first month and often improve significantly by week 8 to 12 as the body adjusts. This dose-dependent response is why a slow, gradual titration schedule reduces dropout rates and improves long-term adherence compared to rapid dose escalation.
Why Semaglutide Causes Gastrointestinal Side Effects
Semaglutide works by activating GLP-1 receptors throughout the digestive system and brain. These receptors regulate appetite, blood sugar, and stomach emptying. When you introduce semaglutide, your stomach slows how fast it moves food into the small intestine—a process called delayed gastric emptying. This sudden change triggers nausea as your digestive system adapts. Additionally, semaglutide signals your brain that you are full, which reduces appetite but can also create mild discomfort or queasiness as you adjust to eating smaller amounts.
The intensity of side effects depends partly on genetics. Your individual GLP-1 receptor sensitivity, determined by specific genetic variants, influences how strongly you respond to the medication. The PlexusDx Precision Peptide Genetic Test analyzes key variants like GLP1R rs6923761 to help identify whether you have heightened receptor sensitivity or other peptide-pathway predispositions that may predict side effect risk. This personalized insight allows your provider to tailor your dosing schedule to minimize discomfort.
Common Semaglutide Side Effects and Their Duration
Nausea is the most frequently reported side effect and typically lasts 2–4 weeks after a dose increase. It often feels mild—similar to mild car sickness—and can be managed with small, frequent meals and staying hydrated. Vomiting is less common and usually mild when it occurs; severe vomiting is rare and often signals a dose that is too high for your current tolerance. Constipation results from slower gastric emptying and reduced food intake; it can persist longer than nausea and may require dietary adjustments or over-the-counter fiber supplements.
Fatigue, headaches, and dizziness are reported by 5–10% of users and typically resolve within the first two weeks. Loss of appetite is intentional but can feel extreme initially—some people report food aversions or changes in taste preference. Acid reflux or heartburn affects a smaller percentage and can usually be managed with antacids. The key takeaway: while side effects are common, most are mild to moderate, temporary, and significantly less bothersome than the initial symptoms that led patients to seek weight loss therapy in the first place.
How PlexusDx Semaglutide Injections Help Minimize Side Effects
PlexusDx Compounded Semaglutide Injection starts at $149/month and is produced by licensed 503A compounding pharmacies in all 50 states with no insurance required. Because PlexusDx works with your provider to customize your dosing schedule based on your tolerance and genetic profile, you can start low and titrate slowly—the proven strategy for minimizing side effects. Your dose may need to go up. Your price won't. This flat-rate pricing model removes the financial barrier to reaching your optimal therapeutic dose without worrying about cost increases.
The Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 14 pathways, 49 peptides, and 150+ genetic insights to predict your individual response profile. Genetic variants in GLP1R, GIPR, FTO, and MC4R influence how your body processes semaglutide and manages appetite signals. With this data, your PlexusDx provider can adjust your starting dose, titration speed, and compound formulation to match your genetic predisposition—reducing unnecessary side effects while accelerating therapeutic benefit. HSA and FSA accounts cover all PlexusDx treatments, making personalized GLP-1 therapy accessible.
When to Contact Your Provider About Side Effects
Mild nausea, constipation, and temporary appetite loss are normal and do not require immediate action—they usually improve on their own. However, you should contact your healthcare provider if you experience severe vomiting that prevents you from keeping food or water down, signs of dehydration (dark urine, extreme thirst, dizziness), severe abdominal pain, or persistent loss of appetite lasting more than two weeks. These symptoms may signal that your current dose is too high or that your body needs additional support.
If side effects are significantly affecting your quality of life, your provider may pause dose increases, reduce your current dose, or adjust your dosing schedule. Some patients benefit from taking smaller amounts more frequently rather than larger doses once weekly. PlexusDx providers work collaboratively to find the dose and schedule that balances efficacy with tolerability—because sustainable weight loss depends on sticking with treatment long-term, not just reaching the highest dose.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What percentage of people on semaglutide experience nausea?
Approximately 25–40% of semaglutide users report nausea in clinical trials, making it the most common side effect. Severity is dose-dependent and typically peaks during the first 2–4 weeks after a dose increase, then improves as your body adapts. PlexusDx providers use a slow titration approach to minimize nausea intensity.
Do side effects from semaglutide go away?
Yes, most side effects are temporary. Nausea, vomiting, and fatigue typically resolve within 2–4 weeks after your body adjusts. Constipation may persist longer but improves with dietary fiber and hydration. By week 8–12, the majority of users experience significant symptom improvement while maintaining therapeutic weight loss benefits.
How much does PlexusDx Semaglutide Injection cost?
PlexusDx Compounded Semaglutide Injection starts at $149/month with flat monthly pricing across all commitment tiers—your dose may increase, but your price won't. Treatment is available in all 50 states without insurance, and HSA/FSA accounts are eligible.
Can genetic testing predict my risk of side effects from GLP-1 therapy?
Yes. The PlexusDx Precision Peptide Genetic Test ($99 add-on) analyzes variants in GLP1R, GIPR, FTO, and MC4R to predict your individual peptide-pathway sensitivity and appetite regulation profile. This insight helps your provider customize your dosing strategy to minimize side effects while maximizing efficacy.
Is compounded semaglutide as safe as brand-name Ozempic?
PlexusDx Semaglutide is produced by licensed 503A compounding pharmacies under strict pharmaceutical standards. While compounded medications are not FDA-approved, 503A compounds are regulated and quality-verified. Your provider determines the appropriate formulation and dose for your individual health profile.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Wegovy Weight Loss Permanent? Understanding Sustainability in Weight Management
Mastering Your Injection: Where to Put Ozempic Shot in Stomach and Proper Technique